Princeton University, University of Pittsburgh School of Medicine, Hospital of the University of Pennsylvania, U. Mass. Medical Center, NCH Heart Institute
Naples, FL
Joined April 2009
- Tweets1.3K
- Following1.3K
- Followers523
- Likes5.5K
David R. Axline, MD, FACC retweeted
In CV imaging, it is essential to ensure that our reports are clinically meaningful, concise, and actionable.
As #CCTA evolves, so must our reports. In this editorial -- accompanying 2026 @Heart_SCCT interpretation and reporting guideline -- we highlight recent changes and future opportunities.
👏 @AnamWaheed05 tinyurl.com/4z6987ar
David R. Axline, MD, FACC retweeted
Heroic save following AMI Shock in a patient with double insult: ventricular pseudoaneurysm and VRS. #innovation #heartteam @NCHRooneyHeart @JACCJournals #Shock #AMI @ACCinTouch @JACCJournals @DeeDeeWangMD @PU84 @DrBrianSolomon
sciencedirect.com/science/ar…
NCH Rooney Heart Institute continues to lead- welcome Dr. Lamelas! @RCubedduMD @NCHRooneyHeart @JosephLamelas
Proud to welcome @JosephLamelas to the @NCHRooneyHeart Institute! - A world leader in minimally invasive #cardiac #surgery, >18,000 career procedures & originator of the #miami method. Advancing care in #Naples #Florida @STS_CTsurgery @AATSHQ @EACTS
David R. Axline, MD, FACC retweeted
NCH Rooney Heart Institute is the first in Florida to offer Abbott’s new MitraClip™ & TriClip™ G5 system—giving high-risk patients with “leaky” heart valves a minimally invasive option to improve symptoms & quality of life. 📄 Read more: bit.ly/45KzhhZ
David R. Axline, MD, FACC retweeted
Is atrial remodeling after AFib catheter ablation a game-changer for heart health? New insights raise the question: How clinically relevant is this process for long-term outcomes? Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio.
David R. Axline, MD, FACC retweeted
Available right now for anyone/everyone with prescriptions, including Medicare w/o part D, uninsured, high copays, prior authorizations denied…
This is the self pay, cash price for 30 day supply mail order
ARNI $62.50
MRA $6.44
BB $6.32
SGLT2i $49.85
costplusdrugs.com
David R. Axline, MD, FACC retweeted
Growing evidence demonstrates that a lower systolic blood pressure of <120 mm Hg significantly reduces #ASCVD risk for patients at high risk.
Check out the expert analysis to learn more ➡️ bit.ly/3I7jbXm #cvPrev
David R. Axline, MD, FACC retweeted
Today, we broke ground on the RM Schulze Family Heart & Stroke Critical Care Center — future home of the @NCHRooneyHeart & NCH Wingard Stroke Institute.
This innovative center will bring together world-class cardiac, vascular, and stroke care under one roof, right here in SWFL.
David R. Axline, MD, FACC retweeted
TAVR for patients with Aortic Regurgitation (AR). Now available. Actively enrolling in the JOURNEY clinical trial @NCHRooneyHeart @NCHFlorida For more information please call 239-624-8387
David R. Axline, MD, FACC retweeted
An excellent expert consensus document on statins in geriatrics. Also advocates for CAC scanning to help decision making (IIa recommendation). i am a strong advocate of treating older active adults with statins
agsjournals.onlinelibrary.wi…
David R. Axline, MD, FACC retweeted
World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group
@vonBardelebenRS @AGIKinterv @DGK_org @EZancanaroMD @KardiologieHH @ESC_Journals @thiele_holger
David R. Axline, MD, FACC retweeted
This #JACCINT retrospective, multicenter, observational study suggests that #SGLT2i may slow the progression of non-severe aortic stenosis! Check out the full paper here: jacc.org/doi/10.1016/j.jcin.… #vhdAS
David R. Axline, MD, FACC retweeted
A new twin study has strengthened the link between tattoos and cancer risk.
For tattoos larger than a palm:
🔺 137% higher risk of skin cancer (HR = 2.37)
🩸 173% higher risk of lymphoma (HR = 2.73)
Let’s break it down 🧵 1/11
David R. Axline, MD, FACC retweeted
According to an updated meta-analysis including 6 RCTs and 5,341 low-risk patients, #TAVR was associated with a reduced hazard of death and death or disabling stroke compared with #SAVR, while rates of stroke were equivalent jacc.org/doi/10.1016/j.jacc.… @JACCJournals
David R. Axline, MD, FACC retweeted
Long-term treatment with finerenone is estimated to extend event-free survival by up to 3 years among people with HF with mildly reduced or preserved ejection fraction. ja.ma/4i9tO8Q @mvaduganathan
David R. Axline, MD, FACC retweeted
#SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis, according to a study published in #JACCINT.
Learn more: bit.ly/4hOrOmA #vhdAS #cvVHD @JACCJournals
